$8.28
0.08[0.98%]
At close: Mar 27
$9.00
0.7200[8.70%]
PreMarket: 8:18AM EDT
Oncternal Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Oncternal Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | PM | ONCT | Q1 | -$4.00 | -$3.07 | — | — | $203.00K | $140.00K | — | — | Get Alert |
03/07/2024 | PM | ONCT | Q4 | -$4.00 | -$3.07 | -$3.11 | -1.30% | $171.00K | $140.00K | $297.00K | 112.14% | Get Alert |
11/09/2023 | PM | ONCT | Q3 | -$4.20 | -$2.80 | -$3.40 | -21.43% | $382.00K | $120.00K | $179.00K | 49.17% | Get Alert |
08/10/2023 | PM | ONCT | Q2 | -$4.60 | -$3.20 | -$3.00 | 6.25% | $191.00K | $200.00K | $106.00K | -47.00% | Get Alert |
05/04/2023 | PM | ONCT | Q1 | -$4.00 | -$4.00 | -$4.00 | 0.00% | $746.00K | $170.00K | $203.00K | 19.41% | Get Alert |
03/09/2023 | PM | ONCT | Q4 | -$3.20 | -$4.20 | -$4.00 | 4.76% | $556.00K | $330.00K | $171.00K | -48.18% | Get Alert |
11/03/2022 | PM | ONCT | Q3 | -$3.80 | -$4.80 | -$4.20 | 12.50% | $2.13M | $310.00K | $382.00K | 23.23% | Get Alert |
08/09/2022 | PM | ONCT | Q2 | -$3.20 | -$4.60 | -$4.60 | 0.00% | $883.00K | $460.00K | $191.00K | -58.48% | Get Alert |
05/05/2022 | PM | ONCT | Q1 | -$2.40 | -$4.00 | -$4.00 | 0.00% | $748.00K | $520.00K | $746.00K | 43.46% | Get Alert |
03/10/2022 | PM | ONCT | Q4 | -$1.80 | — | -$3.20 | — | $1.59M | — | $556.00K | — | Get Alert |
11/04/2021 | PM | ONCT | Q3 | -$4.40 | -$3.20 | -$3.80 | -18.75% | $585.00K | $1.30M | $2.13M | 63.69% | Get Alert |
08/05/2021 | PM | ONCT | Q2 | -$6.80 | -$2.80 | -$3.20 | -14.29% | $623.00K | $1.09M | $883.00K | -18.99% | Get Alert |
05/06/2021 | PM | ONCT | Q1 | -$6.20 | -$2.00 | -$2.40 | -20.00% | $578.00K | $1.11M | $748.00K | -32.61% | Get Alert |
03/11/2021 | PM | ONCT | Q4 | -$5.40 | -$3.60 | -$1.80 | 50.00% | $737.00K | $590.00K | $1.59M | 169.15% | Get Alert |
11/04/2020 | PM | ONCT | Q3 | -$6.40 | — | -$4.40 | — | $544.00K | — | $585.00K | — | Get Alert |
08/06/2020 | PM | ONCT | Q2 | -$67.60 | — | -$6.80 | — | $674.00K | — | $623.00K | — | Get Alert |
05/07/2020 | AM | ONCT | Q1 | — | — | -$6.20 | — | — | — | $578.00K | — | Get Alert |
03/16/2020 | PM | ONCT | Q4 | -$4.20 | — | -$5.40 | — | $477.00K | — | $737.00K | — | Get Alert |
11/07/2019 | PM | ONCT | Q3 | — | — | -$6.40 | — | $329.00K | — | $544.00K | — | Get Alert |
Oncternal Therapeutics (ONCT) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
The Actual EPS was $-3.11, which missed the estimate of $-3.07.
The Actual Revenue was $297K, which beat the estimate of $140K.
Browse earnings estimates, EPS, and revenue on all stocks.